173 related articles for article (PubMed ID: 25725274)
1. Interleukins and inflammatory markers in in-stent restenosis after femoral percutaneous transluminal angioplasty.
Araújo PV; Ribeiro MS; Dalio MB; Rocha LA; Viaro F; Dellalibera Joviliano R; Piccinato CE; Évora PR; Joviliano EE
Ann Vasc Surg; 2015; 29(4):731-7. PubMed ID: 25725274
[TBL] [Abstract][Full Text] [Related]
2. The Role of Interleukins and Inflammatory Markers in the Early Restenosis of Covered Stents in the Femoropopliteal Arterial Segment.
Guimaraes TS; da Rocha LA; Becari C; Piccinato CE; Joviliano RD; Ribeiro MS; Joviliano EE
Ann Vasc Surg; 2018 Jul; 50():88-95. PubMed ID: 29481941
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the kallikrein-kinin system, metalloproteinases, and their tissue inhibitors in the in-stent restenosis after peripheral percutaneous angioplasty.
Ribeiro MS; Dellalibera-Joviliano R; Becari C; Teixeira FR; Araujo PV; Piccinato CE; Campos CP; Evora PR; Joviliano EE
Ann Vasc Surg; 2014 May; 28(4):1005-15. PubMed ID: 24440188
[TBL] [Abstract][Full Text] [Related]
4. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
[TBL] [Abstract][Full Text] [Related]
5. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
[TBL] [Abstract][Full Text] [Related]
6. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
7. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
8. The role of the kallikrein-kinin system, matrix metalloproteinases, and tissue inhibitors of metalloproteinases in the early restenosis of covered stents in the femoropopliteal arterial segment.
Rocha LA; Piccinato CE; Ribiero MS; Becari C; Joviliano RD; Joviliano EE
J Vasc Surg; 2017 Jan; 65(1):119-127. PubMed ID: 27667150
[TBL] [Abstract][Full Text] [Related]
9. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
[TBL] [Abstract][Full Text] [Related]
10. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
11. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
[TBL] [Abstract][Full Text] [Related]
12. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
[TBL] [Abstract][Full Text] [Related]
13. Angioplasty of the common femoral artery and its bifurcation.
Thiney PO; Millon A; Boudjelit T; Della Schiava N; Feugier P; Lermusiaux P
Ann Vasc Surg; 2015 Jul; 29(5):960-7. PubMed ID: 25765633
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts.
Joviliano EE; Piccinato CE; Dellalibera-Joviliano R; Moriya T; Évora PR
Ann Vasc Surg; 2011 Aug; 25(6):846-55. PubMed ID: 21620656
[TBL] [Abstract][Full Text] [Related]
15. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
[TBL] [Abstract][Full Text] [Related]
16. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).
Krankenberg H; Schlüter M; Steinkamp HJ; Bürgelin K; Scheinert D; Schulte KL; Minar E; Peeters P; Bosiers M; Tepe G; Reimers B; Mahler F; Tübler T; Zeller T
Circulation; 2007 Jul; 116(3):285-92. PubMed ID: 17592075
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transluminal angioplasty of lower limb arteries causes a systemic inflammatory response.
Parmar JH; Aslam M; Standfield NJ
Ann Vasc Surg; 2009; 23(5):569-76. PubMed ID: 19467836
[TBL] [Abstract][Full Text] [Related]
18. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
